Rincon Pharmaceuticals

About:

Rincon Pharmaceuticals develops and commercializes recombinant protein therapeutics such as monoclonal antibodies.

Website: https://www.riconpharma.com/

Top Investors: Paperboy Ventures

Description:

Rincon Pharmaceuticals, a biopharmaceutical company, engages in the development, manufacture, and commercialization of recombinant protein therapeutics. It offers monoclonal antibodies. The company was incorporated in 2002 and is based in San Diego, California.

Total Funding Amount:

$4.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2002-01-01

Founders:

Bruce D. Steel, Stephen Mayfield

Number of Employees:

11-50

Last Funding Date:

2005-11-15

IPO Status:

Private

Industries: